Monte Financial Group, LLC Abb Vie Inc. Transaction History

Monte Financial Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $175,377 - $210,323	1,268 New	1,268 $0
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $174,502 - $221,849	-1,268 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $167,350 - $207,635	1,268 New	1,268 $206,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Monte Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Monte Financial Group, LLC with notifications on news.